Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Recalls & Warnings July 30, 2003 Maker of Weight-Loss and Cellulite Treatment Ordered to Stop False Claims and Pay Consumer Redress On July 30, 2003 the Federal Trade Commission (FTC) reported that a Canadian-based company operating in the United States under the name Bio Lab, and its president, Jean-Francois Brochu, have agreed to settle FTC charges that they deceived consumers through false and unsubstantiated advertising
For context, during diet-only weight loss without medication, lean mass loss typically accounts for about 20 to 30% of total weight lost
The formulation of exenatide ER comprises the encapsulation of exenatide IR peptides within 0.06 mm-diameter injectable microspheres made of poly-(D,L lactide-co-glycolide) a biodegradable medical polymer enabling controlled, gradual drug release over an extended period (89)
Use of GLP1 medications, together with research into new therapeutic applications, is fueling a multimillion-dollar market built around this breakthrough.
